|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"liu c j"
Showing items 1101-1150 of 1268 (26 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T08:16:39Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu, C.-S.; Wang, C.-C.;Wang, P.-C.; Lin, H.H.; Tseng, T.-C.; Chen, C.-H.; Su, W.-C.; Liu, C.-J.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Hsu, S.-J.;Lin, J.-W.;Chen, S.-I.;Hung, P.-H.;Tsai, H.-B.;Lai, M.-Y.;Chen, P.-J.;Chen, J.-H.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:10:15Z |
Enhancement of irradiation effects on cancer cells by cross-linked dextran-coated iron oxide (CLIO) nanoparticles
|
Chen, W.-C.; Lai, S.-F.; Liu, C.-J.; Wang, C.-L.; Wang, C.-H.; Chen, H.-H.; Hua, T.-E.; Cheng, Y.-Y.; Wu, M.K.; Hwu, Y.; Yang, C.-S.; Margaritondo, G.; Huang, F.-K.; WEN-CHANG CHEN et al. |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels
|
Tseng, T.-C.;Liu, C.-J.;Wang, C.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chu, J.-S.; Chen, W.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:11:03Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou, Y.-C.;Yu, M.-W.;Wu, C.-F.;Yang, S.-Y.;Lin, C.-L.;Liu, C.-J.;Shin, W.-L.;Chen, P.-J.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU; Chou, YC; CHUN-JEN LIU; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ. |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Genetic variability of hepatitis B virus and response to antiviral therapy
|
Liu, C.-J.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:00:57Z |
A study on the efficacy of body-mind-spirit group therapy for patients with breast cancer
|
Liu, C.J.; Hsiung, P.C.; Chang, K.J.; Liu, Y.F.; Wang, K.C.; Hsiao, F.H.; Ng, S.M.; Chan, Cecilia L.W.;;Liu, Chun-Ju;Hsiung, Ping-Chuan;Chang, King-Jen;Liu, Yu-Fen;Wang, Kuo-Chang;Hsiao, Fei-Hsiu;Ng, Siu-Man;Chan, Cecilia Lw; PING-CHUAN HSIUNG; Liu, Chun-Ju; Liu, C.J.; Liu, C.J.; Hsiung, P.C.; Hsiung, Ping-Chuan; FEI-HSIU HSIAO; Hsiung, P.C.; Chang, King-Jen; Chang, K.J.; Liu, Y.F.; Liu, Y.F.; Liu, Yu-Fen; Wang, Kuo-Chang; Wang, K.C.; Hsiao, Fei-Hsiu; Hsiao, F.H.; Ng, S.M.; Ng, Siu-Man; Chan, Cecilia L.W.; Chan, Cecilia LW |
| 臺大學術典藏 |
2018-09-10T06:59:26Z |
Saddle-shaped dioxo-ruthenium(VI) and -osmium(VI) 2,3,5,7,8,10,12,13,15,17,18,20-dodecaphenylporphyrin (H2dpp) complexes. Synthesis, spectral characterisation and alkene oxidation by [RuVI(dpp)O2]
|
Liu, C.-J.;Yu, W.-Y.;Peng, S.-M.;Mak, T.C.W.;Che, C.-M.; Liu, C.-J.; Yu, W.-Y.; Peng, S.-M.; Mak, T.C.W.; Che, C.-M.; SHIE-MING PENG |
| 臺大學術典藏 |
2018-09-10T06:33:23Z |
Interspousal transmission of GB virus-C/Hepatitis G virus: A comparison with hepatitis C virus
|
Kao, J.-H.;Liu, C.-J.;Chen, P.-J.;Chen, W.;Hsiang, S.-C.;Lai, M.-Y.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:33:22Z |
Benign recurrent intrahepatic cholestasis
|
Liu, C.-J.;Kao, J.-H.;Chen, P.-J.;Lai, M.-Y.;Mao, T.-L.;Wang, T.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:33:21Z |
Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; Tseng, TC; CHUN-JEN LIU; Liu, CJ; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:33:18Z |
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients
|
Wang, C.-C.;Liu, C.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lai, My; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users
|
PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; Lai, MY; JIA-HORNG KAO; Chen, DS; Kao, JH.; Lin, C.-.;Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; Lin, CL; Liu, CJ |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan
|
Tseng, T.-C.; Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Lin, C.-L.; Kao, J.-K.; Chen, D.-S.; CHUN-JEN LIU; Tseng, TC; Liu, CJ; PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; JIA-HORNG KAO; Lai, MY; Lin, CL; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Shao, Yu-Yun; Liu, CJ; PEI-JER CHEN; Lai, MY; DING-SHINN CHEN; Lee, Yi-Hsuan; Hsieh, Min-Shu; JIA-HORNG KAO; Chen, PJ; Kao, JH; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Chen, DS.; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒; Hsu, CS; Hsu, C.-S.; Liu, C.-J.; Lai, M.-Y.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; Lu, Li-Chun; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T06:14:07Z |
Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer
|
Yang, M.-H.;Chang, S.-Y.;Chiou, S.-H.;Liu, C.-J.;Chi, C.-W.;Chen, P.-M.;Teng, S.-C.;Wu, K.-J.; SHU-CHUN TENG |
| 臺大學術典藏 |
2018-09-10T06:12:48Z |
Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma
|
Lin, C.-L.;Chen, J.-D.;Liu, C.-J.;Lee, P.-H.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Lin, CL; PO-HUANG LEE; CHUN-JEN LIU; Chen, JD; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lee, PH; Chen, PJ; Lai, MY; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:00:49Z |
Pegylated interferons for the treatment of chronic hepatitis B.
|
Liu, C.J.;Kao, J.H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:48Z |
Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants
|
Liu, C.-J.;Kao, J.-H.;Chen, P.-J.;Chen, T.-C.;Lin, F.-Y.;Lai, M.-Y.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:47Z |
Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study
|
Liu, C.-J.;Lai, M.-Y.;Chao, Y.-C.;Liao, L.-Y.;Yang, S.-S.;Hsiao, T.-J.;Hsieh, T.-Y.;Lin, C.-L.;Hu, J.-T.;Chen, C.-L.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:47Z |
Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than Answers
|
Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:47Z |
Mixed hepatitis B virus genotype infections: The more, the worse? [3]
|
Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:46Z |
Clinical significance of occult hepatitis B virus infection cannot be overlooked [11]
|
Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:32Z |
Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B
|
Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Lin, F.-Y.; Wang, T.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:27Z |
Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C
|
Chen, B.-F.; Liu, C.-J.; Jow, G.-M.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T05:44:47Z |
Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series
|
Huang, Y.-W.;Liu, C.-J.;Lai, M.-Y.;Lee, P.-H.;Tsai, M.-K.;Wang, S.-S.;Lai, M.-K.;Kao, J.-H.; Huang, Y.-W.; Liu, C.-J.; Lai, M.-Y.; Lee, P.-H.; Tsai, M.-K.; Wang, S.-S.; Lai, M.-K.; Kao, J.-H. |
| 臺大學術典藏 |
2018-09-10T05:25:25Z |
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C
|
Liu, C.-J.;Jeng, Y.-M.;Chen, P.-J.;Lai, M.-Y.;Yang, H.-C.;Huang, W.-L.;Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T05:25:25Z |
Subgenotypes of hepatitis B virus genotype C in Taiwan [3] (multiple letters)
|
Liu, C.-J.;Kao, J.-H.;Chan, H.L.-Y.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T05:25:24Z |
Therapeutic implications of hepatitis B virus genotypes
|
Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T05:25:12Z |
Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan
|
Mah, Y.-H.; Kao, J.-H.; Liu, C.-J.; Chen, C.-L.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; 陳祈玲; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T05:22:23Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu, M.-W.;Yeh, S.-H.;Chen, P.-J.;Liaw, Y.-F.;Lin, C.-L.;Liu, C.-J.;Shih, W.-L.;Kao, J.-H.;Chen, D.-S.;Chen, C.-J.Yu, Ming-Whei; Yeh, Shiou-Hwei; Chen, Pei-Jer; Liaw, Yun-Fan; Lin, Chih-Lin; Liu, Chun-Jen; Shih, Wei-Liang; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Chien-Jen; MING-WHEI YU; Yeh, Shiou-Hwei; CHUN-JEN LIU; Chen, Pei-Jer; Liaw, Yun-Fan; WEI-LIANG SHIH; Lin, Chih-Lin; DING-SHINN CHEN; Liu, Chun-Jen; JIA-HORNG KAO; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Chien-Jen |
| 臺大學術典藏 |
2018-09-10T05:22:21Z |
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
|
Liu, C.-J.;Chen, P.-J.;Jeng, Y.-M.;Huang, W.-L.;Yang, W.-S.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; YUNG-MING JENG; WEI-SHIUNG YANG; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:57:30Z |
Lack of interferon sensitivity-determining region in the genome of hepatitis B virus genotype Ba
|
Liu, C.-J.;Chen, P.-J.;Lai, M.-Y.;Chen, T.-C.;Wang, H.-Y.;Huang, W.-L.;Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:57:28Z |
End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B
|
Liu, C.-J.;Huang, W.-L.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:57:13Z |
Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant Hepatitis
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:57:12Z |
Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma
|
Chen, J.-D.; Liu, C.-J.; Lee, P.-H.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:57:12Z |
High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users
|
Chen, B.-F.;Chen, P.-J.; Jow, G.-M.; Sablon, E.; Liu, C.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:57:11Z |
Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion
|
Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
Showing items 1101-1150 of 1268 (26 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page
|
